Dr. Bubela is Professor and Dean of the Faculty of Health Sciences at Simon Fraser University. Previously she was a Professor in the School of Public Health and Adjunct Professor in the Alberta School of Business at the University of Alberta, Canada. She is a Fellow of the Canadian Academy of Health Sciences and a Fellow of the Royal Society of Canada (elected 2019). She holds a PhD in biology from the University of Sydney and a JD from the University of Alberta. She joined the faculty of the U Alberta in 2004 after clerking for The Honourable Louise Arbour at the Supreme Court of Canada, articling at Field Law LLP in Edmonton, and being called to the bar (Law Society of Alberta) in 2005. Her research program in intellectual property and health law related to translational biomedical research brings together her legal training and a PhD in biology and expertise in genetics and molecular biology. Her research program focuses on large collaborative science networks in genomics, gene therapy, and stem cell biology, addressing barriers to the effective translation of new technologies. These are varied and include ethical issues, effective communication of risks and benefits among stakeholder groups, commercialization and regulation. She provides advice for Government Health and Science agencies as well as life sciences research communities, and patient organisations. Her research is funded by the Canadian Institutes of Health Research, the Canadian Stem Cell Network, Genome Canada, and Alberta Innovates, among others. She co-led research programs on the development of cost-effective personalized medicine and the Alberta Ocular Gene Therapy Team, which is developing novel gene therapies. She has over a hundred publications in law, ethics and science policy journals including Nature, Nature Biotechnology, Cell Stem Cell, PLoS Biology, Trends in Biotechnology, American Journal of Bioethics and Science Translational Medicine.
Tania Bubela
